by Robin MILLARD GENEVA, Switzerland (AFP) — US drugmaker Merck & Co. on Wednesday announced a deal that could see generic versions of its Covid-19 medication widely distributed in poorer countries, in a first during the pandemic. The global Medicines Patent Pool (MPP) said it had signed a voluntary licensing agreement with Merck to facilitate affordable worldwide access for its investigational oral antiviral medicine molnupiravir. Subject to regulatory approval, the deal will help create broad […]